Evidence map›Paper›PMID 34382577›Full record

ArticleThe Journal of endocrinology2021

Loss of apoptosis repressor with caspase recruitment domain (ARC) worsens high fat diet-induced hyperglycemia in mice.

Andrew T Templin, Christine Schmidt, Meghan F Hogan, Nathalie Esser, Richard N Kitsis, Rebecca L Hull, Sakeneh Zraika, Steven E Kahn

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Andrew T TemplinDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, Veteran Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA.
Christine SchmidtDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, Veteran Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA.
Meghan F HoganDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, Veteran Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA.
Nathalie EsserDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, Veteran Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA.
Richard N KitsisDepartments of Medicine and Cell Biology and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, New York, USA.
Rebecca L HullDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, Veteran Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA.
Sakeneh ZraikaDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, Veteran Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA.
Steven E KahnDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, Veteran Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA.
VA Puget Sound Health Care System · USUniversity of Washington · USAlbert Einstein College of Medicine · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Julie Mathieu · 1986 to 2026
$41.4M
Diabetes, Obesity and Metabolism Training ProgramT32DK007247 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON, KRISTINA Marie UTZSCHNEIDER · 1986 to 2026
$10.0M
Nutrition, Obesity and Atherosclerosis Training ProgramT32HL007028 · NHLBI · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1985 to 2026
$6.4M
Impact of Neprilysin on Islet FunctionR01DK098506 · NIDDK · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI ZRAIKA, SAKENEH · 2013 to 2017
$1.5M
The Role of Laminin Alpha 4 in Beta-cell Function and SurvivalF32DK109584 · NIDDK · UNIVERSITY OF WASHINGTON · PI HOGAN, MEGHAN F · 2016 to 2016
$58k
Immune responses to islet amyloid in beta-cell deathIK2BX004659 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI TEMPLIN, ANDREW T. · 2019 to 2023
–
The role of hyaluronan in hIAPP-induced beta cell toxicityI01BX004063 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI WILLIAM A BANKS, REBECCA LUCY HULL-MEICHLE · 2019 to 2026
–
Pathogenesis and Impact of Islet AmyloidI01BX001060 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI Pandora Luke Januszewski · 2011 to 2026
–
BLRD VA I01 BX001060BLRD VA I01 BX004063BLRD VA IK2 BX004659NHLBI NIH HHS T32 HL007028NIDDK NIH HHS F32 DK109584NIDDK NIH HHS P30 DK017047NIDDK NIH HHS R01 DK098506NIDDK NIH HHS T32 DK007247
6 · The paper itself

Abstract

Apoptosis repressor with caspase recruitment domain (ARC) is an endogenous inhibitor of cell death signaling that is expressed in insulin-producing β cells. ARC has been shown to reduce β-cell death in response to diabetogenic stimuli in vitro, but its role in maintaining glucose homeostasis in vivo has not been fully established. Here we examined whether loss of ARC in FVB background mice exacerbates high fat diet (HFD)-induced hyperglycemia in vivo over 24 weeks. Prior to commencing 24-week HFD, ARC-/- mice had lower body weight than wild type (WT) mice. This body weight difference was maintained until the end of the study and was associated with decreased epididymal and inguinal adipose tissue mass in ARC-/- mice. Non-fasting plasma glucose was not different between ARC-/- and WT mice prior to HFD feeding, and ARC-/- mice displayed a greater increase in plasma glucose over the first 4 weeks of HFD. Plasma glucose remained elevated in ARC-/- mice after 16 weeks of HFD feeding, at which time it had returned to baseline in WT mice. Following 24 weeks of HFD, non-fasting plasma glucose in ARC-/- mice returned to baseline and was not different from WT mice. At this final time point, no differences were observed between genotypes in plasma glucose or insulin under fasted conditions or following intravenous glucose administration. However, HFD-fed ARC-/- mice exhibited significantly decreased β-cell area compared to WT mice. Thus, ARC deficiency delays, but does not prevent, metabolic adaptation to HFD feeding in mice, worsening transient HFD-induced hyperglycemia.

Indexed as

AnimalsApoptosis Regulatory ProteinsBlood GlucoseDiet, High-FatHyperglycemiaInsulin-Secreting CellsInsulin SecretionMiceMuscle ProteinsApoptosis Regulatory ProteinsBlood GlucoseMuscle ProteinsNol3 protein, mouseARCcell deathdiabetesisletβ cell

Identifiers

PMID34382577
PMCPMC8651217
OpenAlexW3187251520

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.